The Hidden Market Inside Healthcare: Why Bundled Supply Chains and Narrow Insurance Products Are Both Bets on Power

The Strange Truth About Healthcare Competition

What do a hospital buying bandages and an insurer designing a niche health plan have in common? More than most people think. Both are attempts to solve the same problem in American healthcare: how to buy care at scale without being swallowed by complexity.

That sounds like a management issue, but it is really a market design issue. Healthcare is not one market. It is a maze of mini markets, each with its own gatekeepers, incentives, and blind spots. In one corner, hospital supply chains route billions of dollars through purchasing organizations that promise discounts while collecting fees from manufacturers. In another, insurers like Oscar try to win by offering narrower, more tailored coverage products for specific geographies and patient needs.

The deeper question is not whether these models work. It is this: when does coordination create efficiency, and when does it become a new layer of control that reshapes the market in its own image?

That tension, between efficiency and power, is the real story.

---

Healthcare Does Not Reward Pure Competition

In a textbook market, buyers compare prices, switch easily, and force sellers to improve. Healthcare almost never behaves that way. Hospitals do not buy a few items. They buy tens of thousands of products, from gloves to implants, under pressure, at scale, and often under clinical constraints. Insurance plans do not sell into a neat consumer market either. They must balance premiums, risk pools, provider networks, regulation, and unpredictable utilization.

This is why intermediary structures become so dominant. A hospital group purchasing organization, or GPO, exists because the transaction costs of direct procurement are enormous. Instead of every hospital negotiating with every manufacturer on its own, the GPO aggregates demand. In theory, that gives hospitals leverage. In practice, it creates a powerful market maker that sits between buyer and seller and decides who gets access, volume, and visibility.

Oscar Health represents a different answer to the same complexity. Rather than trying to be everything to everyone, it is leaning into focus: specific states, specific products, and in some cases specific medical needs such as respiratory disease. That is not just a growth tactic. It is a recognition that health insurance becomes more governable when the population is more legible.

The common thread is clear: both models are forms of coordination under fragmentation.

In healthcare, scale is not the opposite of specificity. Often, scale survives only by becoming more specific.

---

The Hidden Tax of Intermediation

Here is the uncomfortable part. Every intermediary claims to reduce friction, but every intermediary also creates its own incentives. GPOs can lower unit prices while still collecting fees from manufacturers. That means the purchasing agent is not merely a neutral broker. It is a business with a revenue model, and that revenue model can subtly influence which products get preferred status.

This is where the moral language of healthcare often fails us. People say, “Are they good or bad?” That is too simple. The real issue is structural: what behaviors does the system reward? If a GPO gets paid based on manufacturer sales, then even if it saves hospitals money on average, it may still favor large incumbents that can offer larger rebates, stronger logistics, and more complex pricing arrangements. The result is not necessarily fraud. It is something more durable and harder to see: institutional inertia disguised as efficiency.

That same pattern appears in insurance, just in a different form. A company like Oscar may improve its medical loss ratio, narrow losses, and grow premium revenue, yet still face pressure to expand geography or launch specialized products just to keep the growth story intact. Tailored plans can help match members to care, but they also create segmentation. Segmentation can improve fit, but it can also exclude messier, higher-cost populations that do not fit cleanly into a product design.

So the hidden tax in healthcare is not always a direct fee. Sometimes it is the cost of systems that become optimized for their own internal stability rather than the patient’s or hospital’s long-term value.

Think of it like an airport security line that becomes so good at processing passengers that it starts selecting for travelers who already know how to game the line. The line gets faster, but the system is no longer neutral. It is sorting people.

---

Two Kinds of Power: Purchasing Power and Product Power

The most useful way to connect these two stories is to distinguish between purchasing power and product power.

Purchasing power belongs to whoever aggregates demand. That is the logic of GPOs. If you can concentrate hospital demand, you can extract discounts, standardize procurement, and control vendor access. The upside is obvious: fewer procurement headaches and potentially lower costs. The downside is equally obvious once you look closely: whoever controls the funnel can shape the market, not just negotiate within it.

Product power belongs to whoever designs a package that feels tailor made to a segment of the market. That is the logic behind narrow exchange strategies, rural expansion, and condition specific offerings. If you can make a product more relevant to a defined group, you can reduce waste, improve retention, and potentially outperform generic competitors. The upside is fit. The downside is that product design can become a filter, excluding people and risks that do not fit the business model.

Together, these forms of power explain a lot of what is happening in modern healthcare. Large systems do not win merely by being big. They win by controlling the terms of choice.

A hospital GPO controls choice upstream, at the point of purchase. A focused insurer controls choice downstream, at the point of coverage. One shapes what hospitals can buy. The other shapes what patients can buy. In both cases, the marketplace does not disappear. It gets compressed into a narrower lane.

This is why healthcare feels paradoxical. Everyone talks about competition, but the winners are often the actors who are best at designing the board on which competition occurs.

---

Why Narrow Can Beat Broad

There is a popular myth in business that broader is always safer. In healthcare, breadth often looks safer only because it hides complexity. Broad products, broad networks, broad procurement catalogs, and broad risk pools can all appear diversified. Yet broadness can also create fog. Fog benefits intermediaries because it makes their coordinating role seem indispensable.

Narrow strategies can outperform broad ones when they solve a painful problem with precision. Oscar’s move toward specific geographies and condition centered products reflects this logic. A plan built around respiratory patients, for example, can potentially do more than bundle insurance benefits. It can guide care navigation, improve member engagement, and create a clearer value proposition for employer groups seeking savings for employees with chronic needs.

That is not just marketing. It is a bet that healthcare customers want less abstraction and more relevance.

The parallel in supply chains is direct. A hospital system does not necessarily need the widest catalog of products. It needs the right items, at the right price, with reliable delivery and clinical confidence. When a GPO works well, it converts chaos into fewer decisions. When it works poorly, it converts chaos into dependence.

So the real strategic question is not “Should we be broad or narrow?” It is: What degree of narrowness produces clarity without creating captivity?

That is the sweet spot every healthcare organization is chasing.

---

A Better Framework: The Three Layers of Healthcare Market Design

To make sense of these dynamics, it helps to use a simple framework with three layers.

1. The Transaction Layer

This is where prices, claims, supplies, and reimbursements are exchanged. GPOs dominate this layer in hospital procurement. Insurers manage it through premiums, cost sharing, and utilization controls. The transaction layer is where most people focus because it produces the clearest numbers.

2. The Routing Layer

This is where decisions are guided before they become transactions. Which vendor gets preferred status? Which member gets placed into which plan? Which geography gets expansion capital? Which product gets emphasized? This is where power becomes subtle, because routing decisions can be justified as operational choices while quietly shaping the market.

3. The Meaning Layer

This is where organizations tell themselves what they are doing. A GPO says it is helping hospitals save money. An insurer says it is helping members find affordable, tailored coverage. Both statements can be true. But the meaning layer is where institutions decide whether they are a neutral utility, a disciplined platform, or a market shaper.

Most failures in healthcare happen when organizations mistake the first layer for the whole system. They celebrate lower costs or higher enrollment while ignoring the routing logic beneath those outcomes. But if the routing layer is flawed, the gains may be temporary.

The most powerful institutions in healthcare are not the ones that merely process demand. They are the ones that decide what demand gets processed in the first place.

---

What This Means for Hospitals, Insurers, and Patients

For hospitals, the lesson is that procurement cannot be treated as an administrative back office function. It is a strategic battlefield. A hospital that assumes its GPO is simply “saving money” may miss the fact that vendor preferences, rebate structures, and access rules are shaping clinical and financial outcomes over time. The question is not just whether a contract is cheap. It is whether the contract preserves optionality.

For insurers, especially those pursuing focused growth, the lesson is that product differentiation is not enough. Narrow plans can work if they genuinely reduce confusion, improve care navigation, and match members to value. But narrowing can also become selection, where the company grows by choosing easier populations rather than by improving care delivery for harder ones. The difference between innovation and cherry picking is often visible only in the long run.

For patients, the lesson is to stop imagining healthcare as a simple seller versus buyer market. It is a layered ecosystem where the terms of access are negotiated long before you ever see a bill. The plan you can buy and the supplies your hospital uses are both downstream outcomes of market design choices that are usually invisible to you.

That invisibility matters. Because once a system becomes too complex to inspect, power can hide inside efficiency language. And once that happens, everyone keeps talking about savings while the structure quietly rearranges who has leverage.

---

Key Takeaways

1. Efficiency and power are not opposites in healthcare. Often, the same structure that lowers costs also concentrates control.

2. Intermediaries are never neutral for long. Whether it is a GPO or a specialized insurer, the revenue model shapes the behavior.

3. Narrow strategies can create real value, but only if they improve fit without creating exclusion. Focus is powerful when it clarifies needs, not when it merely filters out complexity.

4. The most important layer of healthcare competition is routing, not just pricing. Who gets access, preference, and attention often matters more than headline discounts or enrollment growth.

5. Always ask what a system optimizes for. If the answer is its own stability, be cautious. If the answer is long term value for the end user, the model may deserve trust.

---

The Real Lesson: Healthcare Is a Market for Access, Not Just Goods

The deepest connection between hospital purchasing organizations and focused insurance expansion is that both reveal a truth many healthcare debates miss: the scarce resource is not only money, care, or coverage. It is access to the right decision at the right time.

A hospital that can buy supplies intelligently gains access to better economics and possibly better clinical consistency. An insurer that can package coverage intelligently gains access to a segment of members it can actually serve profitably. In both cases, the battlefield is not just the item or the policy. It is the architecture of choice.

That is why healthcare reform is so hard. You cannot simply demand lower prices or more competition and expect the system to obey. You have to redesign the intermediaries, incentives, and pathways that determine which choices are even available.

The next time someone says healthcare just needs more competition, ask a better question: Competition on whose terms? Because in this industry, the real winners are not always the cheapest or the biggest. They are the ones who control the channels through which everyone else must move.